
Alector
Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.
About
Alector is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases such as Alzheimer's, Parkinson's, and frontotemporal dementia. They leverage insights from human genetics, neuroscience, and immunology to create treatments that aim to remove toxic proteins, replace deficient proteins, and restore immune and nerve cell function. The company also develops a proprietary Alector Brain Carrier (ABC) platform to improve drug delivery across the blood-brain barrier.
Similar companies
A biotechnology company developing genetic therapies for rare disorders.
Shares Biotechnology, Pharmaceuticals
Biopharmaceutical company targeting neurodegeneration and aging by modulating the immune system.
Shares Immunology, Biotech
Leveraging the adaptive immune system to diagnose and treat disease.
Shares Biotech, HealthTech
A global oncology company developing and commercializing innovative cancer treatments.
Shares Biotech, MedTech
Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.
Shares Biotech, HealthTech
Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.
Shares Biotech, MedTech
Key facts
- Website
- alector.com
- Headquarters
- South San Francisco, United States
- Founded
- 2013
- Employees
- 151
- Total funding
- $163M (Series E)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 25 Jul 2018 | Series E | $133M | |
| 7 Jan 2016 | Series D | $30M | Dementia Discovery Fund (DDF) |
Tech stack
Detected on alector.com, last scanned 4 Nov 2026. Run your own scan
- Frontend
- jQuery, Tailwind CSS, Bootstrap
- Analytics
- Google Tag Manager
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- Email provider
- Microsoft 365
- Cookie consent
- OneTrust
- Maps
- Google Maps
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is Alector trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Alector is 89 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Alector raised?
Alector has raised a total of $163M in funding. The most recent round on record is Series E.
How many employees does Alector have?
Alector has approximately 151 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Alector:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules


